6,6-Fused heterocyclic ureas as highly potent TRPV1 antagonists-Reference-Cited by-同舟云学术

6,6-Fused heterocyclic ureas as highly potent TRPV1 antagonists

Published:2015-02 Issue:4 Volume:25 Page:803-806
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Sun Wei,Kim Hyo-Shin,Lee Sunho,Jung Aeran,Kim Sung-Eun,Ann Jihyae,Yoon Suyoung,Choi Sun,Lee Jin Hee,Blumberg Peter M.,Frank-Foltyn Robert,Bahrenberg Gregor,Schiene Klaus,Stockhausen Hannelore,Christoph Thomas,Frormann Sven,Lee Jeewoo

Funder

Grunenthal

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference23 articles.

1. The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation

2. Analgesic potential of TRPV1 antagonists

3. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks

4. Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress and challenges of TRPV1 channel modulators as a prospective therapy for diabetic neuropathic pain;European Journal of Medicinal Chemistry;2023-01

2. Solubility Data, Modeling, and Solvent Effect of 8-Isoquinolinamine in Four Mixed Solvents and Ten Monosolvents from 278.15 to 323.15 K;Journal of Chemical & Engineering Data;2022-12-12

3. Investigation on Photophysical, Solvatochromism and Biological Significance of Substituted 2 H ‐Indazole Derivatives;ChemistrySelect;2020-07-02

4. Discovery of dual-acting opioid ligand and TRPV1 antagonists as novel therapeutic agents for pain;European Journal of Medicinal Chemistry;2019-11

5. Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists;Medicinal Research Reviews;2016-12-15